Dietary supplementation of tetradecylthioacetic acid increases feed intake but reduces body weight gain and adipose depot sizes in rats fed on high-fat diets

Diabetes, Obesity and Metabolism

Volumn 11, Issue 11, 2009, Pages 1034-1049

  Wensaas, A J ^a   Rustan, A C ^b   Rokling Andersen, M H ^a   Caesar, R ^a   Jensen, J ^c   Kaalhus, O ^d   Graff, B A ^e   Gudbrandsen, O A ^f   Berge, R K ^g   Drevon, C A ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e Norwegian Knowledge Center for the Health Services   (Norway)

^f UNIVERSITY OF BERGEN   (Norway)

^g HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adipose tissue; Body weight; Energy expenditure; Feed intake; Pan PPAR agonist; Tetradecylthioacetic acid

Indexed keywords

FATTY ACID; FATTY ACID DERIVATIVE; MESSENGER RNA; TETRADECYLTHIOACETIC ACID; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 3;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG MECHANISM; ENERGY EXPENDITURE; EPIDIDYMIS FAT; FATTY ACID OXIDATION; FOOD INTAKE; GENE EXPRESSION; LIPID DIET; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PROTEIN EXPRESSION; RAT; SUBCUTANEOUS FAT; THERAPY EFFECT; WEIGHT GAIN;

ADIPOSITY; ANIMALS; BODY COMPOSITION; DIETARY FATS; DIETARY SUPPLEMENTS; FEEDING BEHAVIOR; MALE; RATS; RATS, WISTAR; SULFIDES; WEIGHT GAIN;

EID: 70350150664     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2009.01092.x     Document Type: Article

References (55)

1. Dowell P, Hu Z, Lane MD. Monitoring energy balance: metabolites of fatty acid synthesis as hypothalamic sensors. Annu Rev Biochem 2005, 74:515-534.
2. Wolfgang MJ, Lane MD. Hypothalamic malonyl-coenzyme A and the control of energy balance. Mol Endocrinol 2008, 22:2012-2020.
3. Erlanson-Albertsson C. The role of uncoupling proteins in the regulation of metabolism. Acta Physiol Scand 2003, 178:405-412.
4. Belzung F, Raclot T, Groscolas R. Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets. Am J Physiol 1993, 264:R1111-8.
5. Rustan AC, Hustvedt BE, Drevon CA. Dietary supplementation of very long-chain n-3 fatty acids decreases whole body lipid utilization in the rat. J Lipid Res 1993, 34:1299-309.
6. Rustan AC, Hustvedt BE, Drevon CA. Postprandial decrease in plasma unesterified fatty acids during n-3 fatty acid feeding is not caused by accumulation of fatty acids in adipose tissue. Biochim Biophys Acta 1998, 1390:245-257.
7. Lau SM, Brantley RK, Thorpe C. The reductive half-reaction in Acyl-CoA dehydrogenase from pig kidney: studies with thiaoctanoyl-CoA and oxaoctanoyl-CoA analogues. Biochemistry 1988, 27:5089-5095.
8. Gottlicher M, Demoz A, Svensson D. Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor. Biochem Pharmacol 1993, 46:2177-2184.
9. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci U. S. A 1997, 94:4312-4317.
10. Raspe E, Madsen L, Lefebvre AM. Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARalpha activation. J Lipid Res 1999, 40:2099-2110.
11. Westergaard M, Henningsen J, Svendsen ML. Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. J Invest Dermatol 2001, 116:702-712.
12. Berge K, Tronstad KJ, Flindt EN. Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways. Carcinogenesis 2001, 22:1747-1755.
13. Berge RK, Tronstad KJ, Berge K. The metabolic syndrome and the hepatic fatty acid drainage hypothesis. Biochimie 2005, 87:15-20.
14. Lovas K, Rost TH, Skorve J. Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation. Diabetes Obes Metab 2009, 11:304-14.
15. Lee HJ, Choi SS, Park MK. Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats. Biochem Biophys Res Commun 2002, 296:293-299.
16. Fu J, Gaetani S, Oveisi F. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 2003, 425:90-93.
17. Guzman M, Lo Verme J, Fu J. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). J Biol Chem 2004, 279:27849-27854.
18. De Vos P, Lefebvre AM, Miller SG. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. J Clin Invest 1996, 98:1004-1009.
19. Larsen PJ, Jensen PB, Sorensen RV. Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis. Diabetes 2003, 52:2249-2259.
20. Madsen L, Guerre-Millo M, Flindt EN. Tetradecylthioacetic acid prevents high fat diet induced adiposity and insulin resistance. J Lipid Res 2002, 43:742-750.
21. Asiedu DK, Skorve J, Willumsen N, Demoz A, Berge RK. Early effects on mitochondrial and peroxisomal beta-oxidation by the hypolipidemic 3-thia-fatty acids in rat livers. Biochim Biophys Acta 1993, 1166:73-76.
22. Asiedu DK, Demoz A, Skorve J, Grav HJ, Berge RK. Acute modulation of rat hepatic lipid metabolism by sulphur-substituted fatty acid analogues. Biochem Pharmacol 1995, 49:1013-1022.
23. Asiedu DK, al-Shurbaji A, Rustan AC. Hepatic fatty acid metabolism as a determinant of plasma and liver triacylglycerol levels. Studies on tetradecylthioacetic and tetradecylthiopropionic acids. Eur J Biochem 1995, 227:715-722.
24. Froyland L, Madsen L, Sjursen W. Effect of 3-thia fatty acids on the lipid composition of rat liver, lipoproteins, and heart. J Lipid Res 1997, 38:1522-1534.
25. Madsen L, Froyland L, Dyroy E, Helland K, Berge RK. Docosahexaenoic and eicosapentaenoic acids are differently metabolized in rat liver during mitochondria and peroxisome proliferation. J Lipid Res 1998, 39:583-593.
26. Madsen L, Garras A, Asins G. Mitochondrial 3-hydroxy-3-methylglutaryl coenzyme A synthase and carnitine palmitoyltransferase II as potential control sites for ketogenesis during mitochondrion and peroxisome proliferation. Biochem Pharmacol 1999, 57:1011-1019.
27. Madsen L, Berge RK. 3-Thia fatty acid treatment, in contrast to eicosapentaenoic acid and starvation, induces gene expression of carnitine palmitoyltransferase-II in rat liver. Lipids 1999, 34:447-456.
28. Grav HJ, Tronstad KJ, Gudbrandsen OA. Changed energy state and increased mitochondrial beta-oxidation rate in liver of rats associated with lowered proton electrochemical potential and stimulated uncoupling protein 2 (UCP-2) expression: evidence for peroxisome proliferator-activated receptor-alpha independent induction of UCP-2 expression. J Biol Chem 2003, 278:30525-30533.
29. Asiedu DK, Froyland L, Vaagenes H. Long-term effect of tetradecylthioacetic acid: a study on plasma lipid profile and fatty acid composition and oxidation in different rat organs. Biochim Biophys Acta 1996, 1300:86-96.
30. Madsen L, Froyland L, Grav HJ, Berge RK. Up-regulated delta 9-desaturase gene expression by hypolipidemic peroxisome-proliferating fatty acids results in increased oleic acid content in liver and VLDL: accumulation of a delta 9-desaturated metabolite of tetradecylthioacetic acid. J Lipid Res 1997, 38:554-563.
31. Vaagenes H, Madsen L, Asiedu DK, Lillehaug JR, Berge RK. Early modulation of genes encoding peroxisomal and mitochondrial beta-oxidation enzymes by 3-thia fatty acids. Biochem Pharmacol 1998, 56:1571-1582.
32. Totland GK, Madsen L, Klementsen B. Proliferation of mitochondria and gene expression of carnitine palmitoyltransferase and fatty acyl-CoA oxidase in rat skeletal muscle, heart and liver by hypolipidemic fatty acids. Biol Cell 2000, 92:317-329.
33. Wergedahl H, Liaset B, Gudbrandsen OA. Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA:cholesterol acyltransferase activity in liver of Zucker rats. J Nutr 2004, 134:1320-7.
34. Franch J, Aslesen R, Jensen J. Regulation of glycogen synthesis in rat skeletal muscle after glycogen-depleting contractile activity: effects of adrenaline on glycogen synthesis and activation of glycogen synthase and glycogen phosphorylase. Biochem J 1999, 344(Pt 1):231-235.
35. Aslesen R, Jensen J. Effects of epinephrine on glucose metabolism in contracting rat skeletal muscles. Am J Physiol 1998, 275:E448-456.
36. Jensen J, Ruzzin J, Jebens E, Brennesvik EO, Knardahl S. Improved insulin-stimulated glucose uptake and glycogen synthase activation in rat skeletal muscles after adrenaline infusion: role of glycogen content and PKB phosphorylation. Acta Physiol Scand 2005, 184:121-130.
37. Willumsen N, Hexeberg S, Skorve J, Lundquist M, Berge RK. Docosahexaenoic acid shows no triglyceride-lowering effects but increases the peroxisomal fatty acid oxidation in liver of rats. J Lipid Res 1993, 34:13-22.
38. Froyland L, Asiedu DK, Vaagenes H. Tetradecylthioacetic acid incorporated into very low density lipoprotein: changes in the fatty acid composition and reduced plasma lipids in cholesterol-fed hamsters. J Lipid Res 1995, 36:2529-2540.
39. Berge RK, Madsen L, Vaagenes H. In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation. Biochem J 1999, 343(Pt 1):191-197.
40. Zhang Y, Proenca R, Maffei M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-32.
41. Chen K, Li F, Li J. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med 2006, 12:425-32.
42. McGarry JD, Leatherman GF, Foster DW. Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. J Biol Chem 1978, 253:4128-4136.
43. Aarsland A, Berge RK. Peroxisome proliferating sulphur- and oxy-substituted fatty acid analogues are activated to acyl coenzyme A thioesters. Biochem Pharmacol 1991, 41:53-61.
44. Skrede S, Bremer J. Acylcarnitine formation and fatty acid oxidation in hepatocytes from rats treated with tetradecylthioacetic acid (a 3-thia fatty acid). Biochim Biophys Acta 1993, 1167:189-196.
45. Skrede S, Sorensen HN, Larsen LN. Thia fatty acids, metabolism and metabolic effects. Biochim Biophys Acta 1997, 1344:115-131.
46. Loftus TM, Jaworsky DE, Frehywot GL. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 2000, 288:2379-81.
47. Wolfgang MJ, Kurama T, Dai Y. The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis. Proc Natl Acad Sci U S A 2006, 103:7282-7.
48. Wolfgang MJ, Cha SH, Millington DS. Brain-specific carnitine palmitoyl-transferase-1c: role in CNS fatty acid metabolism, food intake, and body weight. J Neurochem 2008, 105:1550-1559.
49. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 2001, 291:2613-2616.
50. Chaput E, Saladin R, Silvestre M, Edgar AD. Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight. Biochem Biophys Res Commun 2000, 271:445-450.
51. Lanni A, Mancini F, Sabatino L. De novo expression of uncoupling protein 3 is associated to enhanced mitochondrial thioesterase-1 expression and fatty acid metabolism in liver of fenofibrate-treated rats. FEBS Lett 2002, 525:7-12.
52. Silvestri E, de Lange P, Moreno M. Fenofibrate activates the biochemical pathways and the de novo expression of genes related to lipid handling and uncoupling protein-3 functions in liver of normal rats. Biochim Biophys Acta 2006, 1757:486-495.
53. Park MK, Lee HJ, Hong SH. The increase in hepatic uncoupling by fenofibrate contributes to a decrease in adipose tissue in obese rats. J Korean Med Sci 2007, 22:235-241.
54. Wojtczak L, Wieckowski MR, Schonfeld P. Protonophoric activity of fatty acid analogs and derivatives in the inner mitochondrial membrane: a further argument for the fatty acid cycling model. Arch Biochem Biophys 1998, 357:76-84.
55. Cao H, Gerhold K, Mayers JR. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008, 134:933-944.